This session highlights clinical research advances in metabolic dysfunction-associated steatotic liver disease (MASLD). exploring the role of hepatic steatosis, fibrosis, and inflammation on MASLD.

This scientific session focuses on novel experimental approaches and molecular insights into the pathogenesis of Alcohol-Associated Liver Disease (ALD), exploring potential therapeutic targets for its treatment.

Duke University

Mayo Clinic

Mayo Clinic Rochester

The University of Hong Kong

Cincinnati Children's Hospital Medical Center

University of Pennsylvania